v3.26.1
SEGMENT AND GEOGRAPHIC DATA
 6 Months Ended
Jun. 30, 2026
Segment Reporting [Abstract]  
SEGMENT AND GEOGRAPHIC DATA

NOTE 9 — SEGMENT AND GEOGRAPHIC DATA

 

Operating segments are reported in a manner consistent with the internal reporting provided to the chief operating decision maker. The chief operating decision maker, who is responsible for allocating resources and assessing performance of the operating segments, has been identified as the Chief Executive Officer (the “CODM”). The Company conducts its business through two reportable segments: Dental and Medical. These segments offer different products and services to different customer bases. The CODM assesses the financial performance of the segment and decides how to allocate resources based on Product sales, net, and operating income (loss).

 

The Company provides general corporate services to its segments; however, these services are not considered when making operating decisions and assessing segment performance. These services are reported under “Corporate Services” below, and these include costs associated with executive management, investor relations, patents, trademarks, licensing agreements, new instruments developments, financing activities and public company compliance.

 

 

The following tables present information about our reportable and operating segments for the three and six months ended June 30, 2026, and 2025:

 

 

   Corporate   Dental   Medical   Total 
   Three Months ended June 30, 2026 
   Corporate   Dental   Medical   Grand Total 
Product sales, net   -    2,734,638    106,400    2,841,038 
Cost of products sold   -    906,033    24,838    930,871 
Gross Margin   -    1,828,605    81,562    1,910,167 
                     
Salaries & employee benefits   257,658    396,390    209,249    863,297 
Stock-based compensation expense   254,098    -    -    254,098 
Royalty expense   -    145,430    5,320    150,750 
Marketing   (7,935)   70,049    45,456    107,570 
Rent & occupancy costs   16,722    8,533    5,333    30,588 
Consultants and professional services fees   730,328    34,121    52,810    817,259 
Insurance   41,248    45,554    40,284    127,086 
Warehousing expense   2,458    152,147    20,776    175,381 
Regulatory expense   119,332    8,648    2,312    130,292 
Travel expense   22,458    39,628    25,225    87,311 
Research and development expense   -    6,609    -    6,609 

Depreciation and amortization expense

   19,589    -    -    19,589 
Other segment items   71,549    124,222    6,129    201,900 
Total operating expenses   1,527,505    1,031,331    412,894    2,971,730 
Operating income (loss)   (1,527,505)   797,274    (331,332)   (1,061,563)

 

   Corporate   Dental   Medical   Total 
   Three Months ended June 30, 2025 
   Corporate   Dental   Medical   Grand Total 
Product sales, net   -    2,291,366    32,100    2,323,466 
Cost of products sold   -    704,866    994    705,860 
Gross Margin   -    1,586,500    31,106    1,617,606 
                     
Salaries & employee benefits   206,777    440,463    192,733    839,973 
Stock-based compensation expense   159,678    -    -    159,678 
Royalty expense   -    118,174    1,605    119,779 
Marketing   10,156    48,047    19,907    78,110 
Rent & occupancy costs   21,703    13,852    8,657    44,212 
Consultants and professional services fees   698,388    83,134    119,069    900,591 
Insurance   40,503    45,225    40,078    125,806 
Warehousing expense   5,033    106,685    17,188    128,906 
Regulatory expense   263,931    66,144    3,087    333,162 
Travel expense   12,005    25,870    35,330    73,205 

Research and development expense

   -    47,089    4,700    51,789 

Depreciation and amortization expense

   19,496    -    -    19,496 
Other segment items   79,433    136,193    11,904    227,530 
Total operating expenses   1,517,103    1,130,876    454,258    3,102,237 
                     
Operating income (loss)   (1,517,103)   455,624    (423,152)   (1,484,631)

 

 

   Corporate   Dental   Medical   Total 
   Six Months ended June 30, 2026 
   Corporate   Dental   Medical   Grand Total 
Product sales, net   -    4,789,071    214,000    5,003,071 
Cost of products sold   -    1,490,614    38,266    1,528,880 
Gross Margin   -    3,298,457    175,734    3,474,191 
                     
Salaries & employee benefits   434,908    815,841    437,554    1,688,303 
Stock-based compensation expense   566,261    -    -    566,261 
Royalty expense   -    235,668    10,700    246,368 
Marketing   23,455    106,416    51,424    181,295 
Rent & occupancy costs   36,455    25,599    15,999    78,053 
Consultants and professional services fees   991,573    62,838    154,688    1,209,099 
Insurance   83,074    91,647    80,904    255,625 
Warehousing expense   3,741    283,243    18,177    305,161 
Regulatory expense   208,138    12,133    4,625    224,896 
Travel expense   46,848    64,957    36,036    147,841 
Research and development expense   -    6,609    -    6,609 
Depreciation and amortization expense   39,043    -    -    39,043 
Other segment items   144,884    260,397    10,001    415,282 
Total operating expenses   2,578,380    1,965,348    820,108    5,363,836 
Operating income (loss)   (2,578,380)   1,333,109    (644,374)   (1,889,645)

 

   Corporate   Dental   Medical   Total 
   Six Months ended June 30, 2025 
   Corporate   Dental   Medical   Grand Total 
Product sales, net   -    4,472,536    83,350    4,555,886 
Cost of products sold   -    1,289,761    1,084    1,290,845 
Gross Margin   -    3,182,775    82,266    3,265,041 
                     
Salaries & employee benefits   323,885    881,961    398,847    1,604,693 
Stock-based compensation expense   490,466    -    -    490,466 
Royalty expense   -    228,102    4,168    232,270 
Marketing   14,417    131,676    44,227    190,320 
Rent & occupancy costs   34,411    26,373    16,483    77,267 
Consultants and professional services fees   1,783,082    140,795    261,359    2,185,236 
Insurance   83,375    94,222    82,514    260,111 
Warehousing expense   6,238    219,000    25,961    251,199 
Regulatory expense   328,821    82,994    5,399    417,214 
Travel expense   16,479    57,538    65,292    139,309 
Research and development expense   -    411,896    9,013    420,909 
Depreciation and amortization expense   38,936    -    -    38,936 
Other segment items   152,951    273,239    13,405    439,595 
Total operating expenses   3,273,061    2,547,796    926,668    6,747,525 
Operating income (loss)   (3,273,061)   634,979    (844,402)   (3,482,484)

 

June 30, 2026
   Dental   Medical   Corporate   Total 
Total Assets  $5,271,616   $381,309   $2,694,873   $8,347,798 
    5,271,616    381,309    2,694,873    8,347,798 

 

December 31, 2025
   Dental   Medical   Corporate   Total 
Total Assets  $5,861,323   $394,267   $1,550,839   $7,806,429 
    5,861,323    394,267    1,550,839    7,806,429